Therefore, we demonstrated that U50488H, κ-OR agonists, can improve ERS in cardiomyocytes and relieve myocardial injury in HF rats through activating the Nrf2/HO-1 pathway and regulating Ca2+-SERCA2a to inhibit Ca2+ influx. The gene discussed is HMOX1; the disease is hydrops fetalis.